Practical issues in the use of emollients containing filaggrin modulators in the management of patients with atopic dermatitis and xerosis: Resolution of the Expert board
- 作者: Araviyskaya E.R.1, Bakulev A.L.2, Gadzhigoroeva A.G.3, Elisyutina O.G.4, Zagrtdinova R.M.5, Zaslavsky D.V.6, Ziganshin O.R.7, Ignatovsky A.V.8, Kokhan M.M.9, Kruglova L.S.2, Letyaeva O.I.7, Lvov A.N.2,10, Matushevskaya E.V.11, Medvedeva T.V.12, Migacheva N.B.13, Monakhov K.N.1, Murashkin N.N.2,14,15, Nemchaninova O.B.16, Nenasheva N.M.17, Olisova O.Y.15, Pravdina O.V.18, Pritulo O.A.19, Repetskaya M.N.20, Romanova N.V.21, Samtsov A.V.22, Sidorenko O.A.23, Snarskaya E.S.15, Sokolovskiy E.V.1, Tamrazova O.B.24, Tataurshchikova N.S.24, Fedenko E.S.4, Fedotova N.V.25, Shartanova N.V.4, Shatokhina E.A.2,10, Yusupova L.A.26
-
隶属关系:
- Academician I.P. Pavlov First St. Petersburg State Medical University
- Central State Medical Academy of Department of Presidential Affairs
- Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology
- National Research Center — Institute of Immunology Federal Medical-Biological Agency of Russia
- Izhevsk State Medical Academy
- Saint-Petersburg State Pediatric Medical University
- South-Ural State Medical University
- Saint-Petersburg State University
- Ural Research Institute of Dermatovenereology and Immunopathology
- Lomonosov Moscow State University
- Academy of Postgraduate Education under the Federal state budgetary institution «Federal Scientific and Clinical Center for Specialized Medical Assistance and Medical Technologies of the Federal Medical Biological Agency»
- Research Institute of Medical Mycology named after P.N. Kashkin of North-Western State Medical University named after I.I. Mechnikov
- Samara State Medical University
- National Medical Research Center of Children’s Health
- First Sechenov Moscow State Medical University (Sechenov University)
- Novosibirsk State Medical University
- Russian Medical Academy of Continuous Professional Education
- Omsk State Medical University
- Medical Academy named after S.I. Georgievsky of V.I. Vernadsky Crimean Federal University
- Perm State Medical University
- Yaroslavl State Medical University
- Military medical academy of S.M. Kirov
- Rostov State Medical University
- Peoples’ Friendship University of Russia
- Scientific Research Institute ― Ochapovsky Regional Clinic Hospital
- Kazan State Medical Academy under the Russian Medical Academy of Continuous Professional Education
- 期: 卷 19, 编号 2 (2022)
- 页面: 245-258
- 栏目: Clinical practice guidelines
- URL: https://bakhtiniada.ru/raj/article/view/121765
- DOI: https://doi.org/10.36691/RJA1538
- ID: 121765
如何引用文章
全文:
详细
Leading experts in the field of dermatovenereology, cosmetology, and allergology took part in the meeting of the expert board. Following the discussion, the working groups of the Expert board assessed the role of filaggrin deficiency in the pathogenesis of atopic dermatitis and other diseases/conditions accompanied by xerosis. In addition, they formed recommendations for the use of emollient Admera, taking into account the role of filaggrin in the development of atopic dermatitis and xerosis. The experts comprehensively analyzed the best basic therapy for atopic dermatitis, xerosis of diverse etiologies secondary preventive options for atopic dermatitis and developed unified recommendations on the principles of managing such patients. In addition, they also established the place of emollients in clinical practice. Additional educational, informational, and organizational
activities were proposed to help patients and doctors understand the problem of using emollients in atopic dermatitis and xerosis of diverse etiologies.
This article was first published in the Kremlin Medicine Journal (Kruglova LS, Lvov AN, Araviyskaya ER, et al. Practical issues on the application of emollients containing filaggrin modulators in the management of patients with atopic dermatitis and xerosis. Resolution of the Council of experts. Kremlin Medicine Journal. 2022;1:87–94. doi: 10.26269/m4bj-f167). This article published with permission from authors and copyright holder.
作者简介
Elena Araviyskaya
Academician I.P. Pavlov First St. Petersburg State Medical University
Email: arelenar@mail.ru
ORCID iD: 0000-0002-6378-8582
SPIN 代码: 9094-9688
MD, MD, Dr. Sci. (Med.), Professor
俄罗斯联邦, Saint PetersburgAndrey Bakulev
Central State Medical Academy of Department of Presidential Affairs
Email: al_ba05@mail.ru
ORCID iD: 0000-0002-1450-4942
SPIN 代码: 6708-7386
MD; Dr. Sci. (Med.), Professor
俄罗斯联邦, MoscowAida Gadzhigoroeva
Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology
Email: aida2010@mail.ru
ORCID iD: 0000-0003-0489-0576
MD, Dr. Sci. (Med.), Professor
俄罗斯联邦, MoscowOlga Elisyutina
National Research Center — Institute of Immunology Federal Medical-Biological Agency of Russia
编辑信件的主要联系方式.
Email: el-olga@yandex.ru
ORCID iD: 0000-0002-4609-2591
SPIN 代码: 9567-1894
MD, Dr. Sci. (Med.)
俄罗斯联邦, 24, Kashirskoyw shosse, Moscow, 115522Rizida Zagrtdinova
Izhevsk State Medical Academy
Email: kafedra.derma@yandex.ru
ORCID iD: 0000-0003-0565-9149
MD, Dr. Sci. (Med.), Professor
俄罗斯联邦, IzhevskDenis Zaslavsky
Saint-Petersburg State Pediatric Medical University
Email: venerology@gmail.com
ORCID iD: 0000-0001-5936-6232
SPIN 代码: 5832-9510
MD, Dr. Sci. (Med.), Professor
俄罗斯联邦, Saint PetersburgOleg Ziganshin
South-Ural State Medical University
Email: ziganshin_oleg@mail.ru
ORCID iD: 0000-0002-5857-0319
SPIN 代码: 5339-2533
MD, Dr. Sci. (Med.), Professor
俄罗斯联邦, ChelyabinskAndrey Ignatovsky
Saint-Petersburg State University
Email: derm@list.ru
ORCID iD: 0000-0003-3048-2488
SPIN 代码: 8500-0451
MD, Cand. Sci. (Med.), Assistant Professor
俄罗斯联邦, Saint PetersburgMuza Kokhan
Ural Research Institute of Dermatovenereology and Immunopathology
Email: mkokhan@yandex.ru
ORCID iD: 0000-0001-6353-6644
SPIN 代码: 3470-9306
MD, Dr. Sci (Med.), Professor
俄罗斯联邦, EkaterinburgLarisa Kruglova
Central State Medical Academy of Department of Presidential Affairs
Email: kruglovals@mail.ru
ORCID iD: 0000-0002-5044-5265
SPIN 代码: 1107-4372
MD, Dr. Sci. (Med.), Professor
俄罗斯联邦, MoscowOlga Letyaeva
South-Ural State Medical University
Email: olga-letyaeva@yandex.ru
ORCID iD: 0000-0002-9085-6229
SPIN 代码: 3312-3150
MD, Dr. Sci. (Med.), Professor
俄罗斯联邦, ChelyabinskAndrey Lvov
Central State Medical Academy of Department of Presidential Affairs; Lomonosov Moscow State University
Email: alvov@mail.ru
ORCID iD: 0000-0002-3875-4030
SPIN 代码: 1053-3290
MD, Dr. Sci. (Med.), Professor
俄罗斯联邦, Moscow; MoscowElena Matushevskaya
Academy of Postgraduate Education under the Federal state budgetary institution «Federal Scientific and Clinical Center for Specialized Medical Assistance and Medical Technologies of the Federal Medical Biological Agency»
Email: matushevskaya@mail.ru
ORCID iD: 0000-0003-4583-0617
SPIN 代码: 7430-2112
MD, Dr. Sci. (Med.), Professor
俄罗斯联邦, MoscowTatiana Medvedeva
Research Institute of Medical Mycology named after P.N. Kashkin of North-Western State Medical University named after I.I. Mechnikov
Email: medvedeva43@mail.ru
ORCID iD: 0000-0002-6983-6071
SPIN 代码: 5494-6144
MD, Cand. Sci. (Med.), Assistant Professor
俄罗斯联邦, Saint PetersburgNatalia Migacheva
Samara State Medical University
Email: nbmigacheva@gmail.com
ORCID iD: 0000-0003-0941-9871
SPIN 代码: 1313-9021
MD, Dr. Sci. (Med.), Assistant Professor
俄罗斯联邦, SamaraKonstantin Monakhov
Academician I.P. Pavlov First St. Petersburg State Medical University
Email: knmonakhov@gmail.com
ORCID iD: 0000-0002-8211-1665
SPIN 代码: 1837-2098
MD, Dr. Sci. (Med.), Professor
俄罗斯联邦, Saint PetersburgNikolay Murashkin
Central State Medical Academy of Department of Presidential Affairs; National Medical Research Center of Children’s Health; First Sechenov Moscow State Medical University (Sechenov University)
Email: m_nn2001@mail.ru
ORCID iD: 0000-0003-2252-8570
SPIN 代码: 5906-9724
MD, Dr. Sci. (Med.)
俄罗斯联邦, Moscow; Moscow; MoscowOlga Nemchaninova
Novosibirsk State Medical University
Email: obnemchaninova@mail.ru
ORCID iD: 0000-0002-5961-6980
SPIN 代码: 5658-9359
MD, Dr. Sci. (Med.), Professor
俄罗斯联邦, NovosibirskNatalia Nenasheva
Russian Medical Academy of Continuous Professional Education
Email: 1444031@gmail.com
ORCID iD: 0000-0002-3162-2510
SPIN 代码: 3363-6170
MD, Dr. Sci. (Med.), Professor
俄罗斯联邦, MoscowOlga Olisova
First Sechenov Moscow State Medical University (Sechenov University)
Email: olisovaolga@mail.ru
ORCID iD: 0000-0003-2482-1754
SPIN 代码: 2500-7989
MD, Dr. Sci. (Med.), Professor
俄罗斯联邦, MoscowOlga Pravdina
Omsk State Medical University
Email: pravdina76@yandex.ru
ORCID iD: 0000-0002-1804-6248
SPIN 代码: 9338-3941
MD, Cand. Sci. (Med.), Assistant Professor
俄罗斯联邦, OmskOlga Pritulo
Medical Academy named after S.I. Georgievsky of V.I. Vernadsky Crimean Federal University
Email: 55550256@mail.ru
ORCID iD: 0000-0001-6515-1924
SPIN 代码: 2988-8463
MD, Dr. Sci. (Med.), Professor
俄罗斯联邦, SimferopolMarina Repetskaya
Perm State Medical University
Email: proffrep@yandex.ru
ORCID iD: 0000-0002-2001-4296
SPIN 代码: 4293-6683
MD, Dr. Sci. (Med.), Professor
俄罗斯联邦, PermNadezhda Romanova
Yaroslavl State Medical University
Email: n.v.romanova@mail.ru
ORCID iD: 0000-0003-3831-0912
SPIN 代码: 4781-2770
MD, Dr. Sci. (Med.), Assistant Professor
俄罗斯联邦, YaroslavlAlexey Samtsov
Military medical academy of S.M. Kirov
Email: avsamtsov@mail.ru
ORCID iD: 0000-0002-9458-0872
MD, Dr. Sci. (Med.), Professor
俄罗斯联邦, Saint PetersburgOlga Sidorenko
Rostov State Medical University
Email: ola_ps@mail.ru
ORCID iD: 0000-0002-7387-2497
SPIN 代码: 2209-0521
MD, Dr. Sci. (Med.), Professor
俄罗斯联邦, Rostov-on-DonElena Snarskaya
First Sechenov Moscow State Medical University (Sechenov University)
Email: snarskaya-dok@mail.ru
ORCID iD: 0000-0002-7968-7663
SPIN 代码: 3785-7859
MD, Dr. Sci. (Med.), Professor
俄罗斯联邦, MoscowEvgeny Sokolovskiy
Academician I.P. Pavlov First St. Petersburg State Medical University
Email: s40@mail.ru
ORCID iD: 0000-0001-7610-6061
SPIN 代码: 6807-7137
MD, Dr. Sci. (Med.), Professor
俄罗斯联邦, Saint PetersburgOlga Tamrazova
Peoples’ Friendship University of Russia
Email: anait_tamrazova@mail.ru
ORCID iD: 0000-0003-3261-6718
SPIN 代码: 5476-8497
MD, Dr. Sci. (Med.), Professor
俄罗斯联邦, MoscowNatalia Tataurshchikova
Peoples’ Friendship University of Russia
Email: natalytataur@yandex.ru
ORCID iD: 0000-0002-3486-8188
SPIN 代码: 4992-3581
MD, Dr. Sci. (Med.), Professor
俄罗斯联邦, MoscowElena Fedenko
National Research Center — Institute of Immunology Federal Medical-Biological Agency of Russia
Email: efedks@gmail.com
ORCID iD: 0000-0003-3358-5087
SPIN 代码: 5012-7242
MD, Dr. Sci. (Med.), Professor
俄罗斯联邦, 24, Kashirskoyw shosse, Moscow, 115522Natalia Fedotova
Scientific Research Institute ― Ochapovsky Regional Clinic Hospital
Email: nfedotova23@mail.ru
ORCID iD: 0000-0003-0631-7212
SPIN 代码: 2002-2618
MD, Cand. Sci. (Med.)
俄罗斯联邦, KrasnodarNatalia Shartanova
National Research Center — Institute of Immunology Federal Medical-Biological Agency of Russia
Email: nshartanova@yandex.ru
ORCID iD: 0000-0002-1197-9002
SPIN 代码: 6483-8901
MD, Dr. Sci. (Med.)
俄罗斯联邦, 24, Kashirskoyw shosse, Moscow, 115522Eugenia Shatokhina
Central State Medical Academy of Department of Presidential Affairs; Lomonosov Moscow State University
Email: e.a.shatokhina@gmail.com
ORCID iD: 0000-0002-0238-6563
SPIN 代码: 3827-0100
MD, Dr. Sci. (Med.), Professor
俄罗斯联邦, Moscow; MoscowLuiza Yusupova
Kazan State Medical Academy under the Russian Medical Academy of Continuous Professional Education
Email: yuluizadoc@hotmail.com
ORCID iD: 0000-0001-8937-2158
SPIN 代码: 5743-6872
MD, Dr. Sci. (Med.), Professor
俄罗斯联邦, Kazan参考
- Kruglova LS, Lvov AN, Araviyskaya ER, et al. Practical issues on the application of emollients containing filaggrin modulators in the management of patients with atopic dermatitis and xerosis. Resolution of the Council of experts. Kremlin Medicine Journal. 2022;1:87–94. (in Russ) doi: 10.26269/m4bj-f167
- Bragina EE. Filagrin and keratins in the formation of a protective barrier. Plastic Sur Cosmetology. 2011;(4):651–660. (In Russ).
- Barker JN, Palmer CN, Zhao Y, et al. Null mutations in the filaggrin gene (FLG) determine major susceptibility to early-onset atopic dermatitis that persists into adulthood. J Invest Dermatol. 2007;127(3):564–567. doi: 10.1038/sj.jid.5700587
- Ehrhardt P, Brandner Johanna M, Jens-Michael J. The skin: an indispensable barrier. Experimental Dermatol. 2008;17(12): 1063–1072. doi: 10.1111/j.1600-0625.2008.00786.x
- Proksch E, Brandner JM, Jensen JM. The skin: an indispensable barrier. Exp Dermatology. 2008;17(12):1063–1072. doi: 10.1111/j.1600-0625.2008.00786.x
- Presland RB, Fleckman P, Haydock PV, et al. Characterization of the human epidermal profilaggrin gene: Genomic organization and identification of an S-100-like calcium binding domain at the amino terminus. J Biol Chem. 1992;267(33):23772–23781.
- Irvine AD, McLean WH, Leung DY. Filaggrin mutations associated with skin and allergic diseases. N Engl J Med. 2011;365(14): 1315–1327. doi: 10.1056/NEJMra1011040
- Araviyskaya ER, Sokolovsky EV. Dry skin. Causes of occurrence. Principles of correction. Dermatovenerology Cosmetology. 2002;(2): 23–25. (In Russ).
- Funikova A. Atopic dermatitis. New aspects of pathogenesis, modern research. Criteria for diagnosis. Cosmetologist. 2013;(1). (In Russ).
- Komova EG, Shintyapina AB, Makarova SI, et al. Filaggrin mutations in a Western Siberian population and their association with atopic dermatitis in Children. Genet Test Mol Biomarkers. 2014;18(12):791–796. doi: 10.1089/gtmb.2014.0247
- Smith FJ, Irvine AD, Terron-Kwiatkowski A, et al. Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris. Nat Genet. 2006;38(3):337–342. doi: 10.1038/ng1743
- Sandilands A, O’Regan GM, Liao H, et al. Prevalent and rare mutations in the gene encoding filaggrin cause ichthyosis vulgaris and predispose individuals to atopic dermatitis. J Invest Dermatol. 2006;126(8):1770–1775. doi: 10.1038/sj.jid.5700459
- Clark AG, Hubisz MJ, Bustamante CD, et al. Ascertainment bias in studies of human genome-wide polymorphism. Genome Res. 2005;15(11):1496–1502. doi: 10.1101/gr.4107905
- Visser MJ, Landeck L, Campbell LE, et al. Impact of atopic dermatitis and loss-of-function mutations in the filaggrin gene on the development of occupational irritant contact dermatitis. Br J Dermatol. 2013;168(2):326–332. doi: 10.1111/bjd.12083
- McAleer MA, Irvine AD. The multifunctional role of filaggrin in allergic skin disease. J Allergy Clin Immunol. 2013;131(2):280–291. doi: 10.1016/j.jaci.2012.12.668
- Liljedahl RE, Johanson G, Korres de Paula H, et al. Filaggrin polymorphisms and the uptake of chemicals through the skin-a human experimental study. Environ Health Perspect. 2021;129(1):17002. doi: 10.1289/EHP7310
- Brown SJ, Kroboth K, Sandilands A, et al. Intragenic copy number variation within filaggrin contributes to the risk of atopic dermatitis with a dose-dependent effect. J Invest Dermatol. 2012;132(1): 98–104. doi: 10.1038/jid.2011.342
- Volosovets AP, Krivopustov SP, Pavlik EV. The role of filaggrin in the allergology of childhood. Child’s Health. 2013;(2): 156–161. (In Russ).
- Maksimova YV, Svechnikova EV, Maksimov VN, Lykova SG. Heredity and atopic dermatitis [Electronic resource]. Med Education Siberia: Online Scientific Publication. 2013;(6). (In Russ).
- Rupnik H, Rijavec M, Korošec P. Filaggrin loss-of-function mutations are not associated with atopic dermatitis that develops in late childhood or adulthood. Br J Dermatol. 2015;172(2):455–461. doi: 10.1111/bjd.13477
- Brown SJ, Irvine AD. Atopic eczema and the filaggrin story. Semin Cutan Med Surg. 2008;27(2):128–137. doi: 10.1016/j.sder.2008.04.001
- Thaçi D, Simpson EL, Beck LA, et al. Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial. Lancet. 2016;387(10013): 40–52. doi: 10.1016/S0140-6736(15)00388-8
- Cornelissen C, Marquardt Y, Czaja K, et al. IL-31 regulates differentiation and filaggrin expression in human organotypic skin models. J Allergy Clin Immunol. 2012;129(2):426–433, 433.e1-8. doi: 10.1016/j.jaci.2011.10.042
- Sandilands A, Sutherland C, Irvine AD, McLean WH. Filaggrin in the frontline: role in skin barrier function and disease. J Cell Sci. 2009;122(Pt 9):1285–1294. doi: 10.1242/jcs.033969
- Belozerova AP. Indicators of sensitization to antigens of opportunistic fungi Malassezia and Candida in patients with allergodermatoses with mutations of the filaggrin gene. Dermatol Venereol. 2011;(4):24. (In Russ).
- Heede NG, Thyssen JP, Thuesen BH, et al. Anatomical patterns of dermatitis in adult filaggrin mutation carriers. J Am Acad Dermatol. 2015;72(3):440–448. doi: 10.1016/j.jaad.2015.01.001
- Active Epidermal Moisturization: Filaggrin Modulator from Fractions of vegetable Unsaponifiables. Lexicon Vevy Europe. 2011;(1):1–4.
- Presland RB, Boggess D, Lewis SP, et al. Loss of normal profilaggrin and filaggrin in flaky tail (ft/ft) mice: an animal model for the filaggrin-deficient skin disease ichthyosis vulgaris. J Invest Dermatol. 2000;115(6):1072–1081. doi: 10.1046/j.1523-1747.2000.00178.x
- Smith FJ, Irvine AD, Terron-Kwiatkowski A, et al. Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris. Nat Genet. 2006;38(3):337–342. doi: 10.1038/ng1743
- Favre A, Donetti M. Studio istochimico dell’ATPasi dopo applicazione cutanea di Filagrinol. Lexicon Vevy. 1987;(4):49–51.
- Rialdi G, Hauf E. Evaluation of the effects of Filagrinol on human skin. Lexicon Vevy. 1988;(3):30–38.
- Rialdi G, Hauf E. Biochemical Evaluation of Filagrinol protection on the skin aspect through time (skin momentum). Lexicon Vevy Europe. 1988;2:16–20.
- Zaslavsky DV, Sobolev AV, Skrek SV, et al. Normalization of the epidermal barrier as a method of pathogenetic therapy of atopic dermatitis in children. Bulletin Dermatol Venereol. 2021;97(5):52–65. (In Russ). doi: 10.25208/vdv1255
- Murashkin NN, Ivanov RA, Ambarchyan ET, et al. Filaggrin and atopic dermatitis: clinical and pathogenetic parallels and possibilities of therapeutic correction. Issues Modern Pediatrics. 2021;20(5): 435–440. doi: 10.15690/vsp.v20i5.2320
补充文件
